Drugs / TM5614
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT04634799 Comparator | Jan 2021 → Apr 2025 | COVID-19 | Northwestern University | Suspended | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TM5614 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04634799 ↗ |
| Action | Inhibit | “a small molecule inhibitor of PAI-1, TM5614” NCT04634799 ↗ |
| Modality | Small molecule | “a novel small molecule therapy targeting PAI-1 (TM5614)” NCT04634799 ↗ |